 JUPITER, Fla., Oct. 27, 2022 GLOBE NEWSWIRE -- Dyadic International, Inc. Dyadic, we, us, our, or the Company NASDAQ: DYAI, a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and animal health, today announced that it will report its financial results for the third quarter 2022 and host a corporate update conference call on Thursday, November 10, 2022. 